Thank you, Quinn. My comments will generally follow the slide presentation and we'll start with slide number three to recap the quarter. As mentioned adjusted net income of $24.5 million represented a record third quarter. Since adjusted net income is a non-GAAP measure, we provide full reconciliations to the reported figures and these can be found in Appendix 2 of the presentation and Table 2 of our press release. Specifically regarding adjustments to reported net income, this quarter included only deferred compensation expense of $4.1 million or $0.17 per diluted share whereas the same period of the prior year had $3.8 million of income or $0.17 per diluted share. The expense for the current quarter was due to a 22% increase in Stepan's stock from the end of the second quarter of 2016 to the end of the third quarter of 2016. Naturally all employee compensation expenses reflected in our normal operating income; however, we also allow employees the opportunity to defer their payouts until some future date and the future payment changes based on the Company's stock price. When the stock price increases expense is generated. Since the future liability of employee compensation only changes consistently with the change in the stock price, we exclude this item from our operational discussion discussions. Surfactant income was $20.7 million down $1.1 million or 5% versus the third quarter of 2015, due to lower results in Europe and Latin America partially offset by North America lower raw material cost and higher volumes as well as operational improvements. North America was negatively impacted by cost related to the Canadian plant shutdown, which was previously reported. Polymer operating income was $27.1 million, up $2.5 million or 10% versus the third quarter of 2015. This increase was due to volume growth within the Global Rigid Polyol business, partially offset by cost related to the 30 day government mandated shutdown in Germany which has been completed. Specialty product operating income was $2.3 million, up $2.6 million versus the third quarter of 2015 on improved lipid nutrition results and timing of orders in our pharmaceutical and flavor businesses. Let’s move to Slide 4, which shows the total company's earnings bridge for the third quarter compared to last year’s third quarter and breaks down the $3.4 million increase in adjusted net income. Since this is net income, the figures noted here are after the effective taxes. We will cover each segment in more details, but polymers continue to deliver operating income growth compared to the prior year while Surfactant was down slightly. In the fourth quarter, we announced that we exited our TIORCO joint venture with Nalco which was focused on the enhanced oil recovery market. As a result, we no longer recognize losses from the equity in that joint venture. We remain committed to that market over the short and longer term, but we’ll serve it through a smaller more focused set of resources. This item was previously shown separately below operating income on our income statement. But going forward, all commercial benefits and the related costs will be reported entirely within the global Surfactant segment. The all other category primarily represents the favorable impact of not having external consulting fees in the third quarter of 2016, related to our ongoing global efficiency initiative which is called DRIVE. This initiative is now internally managed and the related benefits are captured within each business segment operating results. Our discussion on Slide 5 focuses solely on Surfactant business for the quarter. Surfactant sales were $290.5 million down slightly from the same quarter a year ago. Prices increased slightly due to higher selling prices that contractually followed higher raw material cost, were completely offset by the negative impact of foreign currency translation. Sales volume was flat compared to the prior year, as higher volume in North America was offset by lower volumes in Latin America and Europe. The segment delivered $20.7 million of operating income, a decrease of $1.1 million over the third quarter of 2015. We show North America and Asia in the same category because our Surfactant business in Asia is relatively small and much of our surfactant production in the region is used to support business in the U.S. These regions benefited from higher volumes, lower raw material cost, contributions from our internal efficiency initiative and improved product mix in the Philippines. Accelerated depreciation related to the previously announced full shutdown of our Canadian plant negatively impacted operating income by $1.3 million. Latin America was down due to lower volumes in Brazil and Colombia. Following a record year in 2015 Europe results were down due to lower demand in our consumer product and distribution businesses. Now turning to the Polymer discussion on Slide 6, sales were $134.1 million essentially flat as compared to the same quarter last year. Prices were down 10% partially because lower pricing related to the lower raw material cost in that segment. The negative impact of foreign currency translation lowered sales by 1% while volumes were up 11%. Operating income was $27.1 million or $2.5 million higher compared to the same quarter of last year. Global Rigid Polyol volumes were 14% higher over prior year due to increased installation standards and higher volumes to metal panel applications. Construction of our Specialty Polyol reactor in Poland is complete and production is expected to start in the fourth quarter. Europe results were negatively impacted by cost related to a plant 30 day government mandated shutdown at our site in Germany, which is required every five years. However, the plant is now operating at full production rates. In China, export shipments and lower cost reduced our expected losses for the year. Phthalic Anhydride results decreased slightly over prior year at lower sales volume. Now, Quinn will cover Slide 7 and discuss some of our expectations for the remainder of 2016.